Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly operating margin; no daily interpolation. Q4 FY2026 (2026-03-31): -65.42%.
OPERATING MARGIN
N/A
OPERATING MARGIN AVG TTM
-363.61%
OPERATING MARGIN AVG 3Y
-173.09%
OPERATING MARGIN AVG 5Y
-119.19%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
China SXT Pharmaceuticals, Inc.
Market Cap
$667469.00
Operating Margin
N/A
TTM Avg
-363.61%
3Y Avg
-173.09%
5Y Avg
-119.19%
Market Cap
$716854.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$545796.00
Operating Margin
-20757.65%
TTM Avg
-10953.08%
3Y Avg
-5758.86%
5Y Avg
-3862.92%
Market Cap
$518606.00
Operating Margin
-8567.94%
TTM Avg
-8664.53%
3Y Avg
-8990.40%
5Y Avg
-6121.14%
Market Cap
$824550.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-24.80%
Market Cap
$835994.00
Operating Margin
N/A
TTM Avg
-1.14%
3Y Avg
-4.66%
5Y Avg
-4.48%
Market Cap
$838843.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-935.37%
5Y Avg
-623.58%
Market Cap
$481786.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$868077.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| China SXT Pharmaceuticals, Inc. (SXTC) | $667469.00 | N/A | -363.61% | -173.09% | -119.19% |
| CDT Equity Inc. (CDT)vs › | $716854.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | -20757.65% | -10953.08% | -5758.86% | -3862.92% |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | -8567.94% | -8664.53% | -8990.40% | -6121.14% |
| Decoy Therapeutics Inc. (DCOY)vs › | $824550.00 | 0.00% | 0.00% | 0.00% | -24.80% |
| Ridgetech, Inc. (RDGT)vs › | $835994.00 | N/A | -1.14% | -4.66% | -4.48% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $838843.00 | 0.00% | 0.00% | -935.37% | -623.58% |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Bone Biologics Corporation (BBLG)vs › | $868077.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | -65.42% |
| 2025-12-31 | -153.28% |
| 2025-09-30 | -1011.69% |
| 2025-03-31 | -224.07% |
| 2024-12-31 | -224.07% |
| 2024-09-30 | -76.95% |
| 2024-06-30 | -76.95% |
| 2024-03-31 | 6.07% |
| 2023-12-31 | 454.94% |
| 2023-09-30 | -520.45% |
| 2023-06-30 | -995.02% |
| 2023-03-31 | -222.67% |
| 2022-12-31 | -583.85% |
| 2022-09-30 | -95.21% |
| 2022-06-30 | -95.21% |
| 2022-03-31 | -25.58% |
| 2021-12-31 | -145.95% |
| 2021-09-30 | -58.45% |
| 2021-06-30 | -281.37% |
| 2021-03-31 | -48.71% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 30.15% |
| 2020-06-30 | 30.15% |
| 2020-03-31 | -46.20% |
| 2019-12-31 | -57.54% |
| 2019-09-30 | 195.84% |
| 2019-06-30 | -6.87% |
| 2019-03-31 | 14.30% |
| 2018-12-31 | 14.30% |
| 2018-09-30 | 33.87% |
| 2018-06-30 | 33.87% |
| 2018-03-31 | 20.94% |
| 2017-12-31 | 23.85% |
| 2017-09-30 | 26.91% |
| 2017-06-30 | 26.91% |
| 2017-03-31 | 44.08% |
